摘要
<jats:title>Abstract</jats:title><jats:p>SARS-CoV-2 gains entry to human cells through its spike (S) protein binding to angiotensin-converting enzyme 2 (ACE2). Therefore, the receptor binding domain (RBD) of the S protein is the primary target for neutralizing antibodies. Selection of broad-neutralizing antibodies against SARS-CoV-2 and SARS-CoV is attractive and might be useful for treating not only COVID-19 but also future SARS-related CoV infections. Broad-neutralizing antibodies, such as 47D11, S309, and VHH-72, have been reported to target a conserved region in the RBD of the S1 subunit. The S2 subunit required for viral membrane fusion might be another target. Due to their small size and high stability, single-domain antibodies might have the ability to be administered by an inhaler making them potentially attractive therapeutics for respiratory infections. A cocktail strategy combining two (or more) antibodies that recognize different parts of the viral surface that interact with human cells might be the most effective.</jats:p>
- Human neutralizing antibodies elicited by SARS-CoV-2 infectionJu, Bin; Zhang, Qi; Ge, Jiwan; Wang, Ruoke; Sun, Jing; Ge, Xiangyang; Yu, Jiazhen; Shan, Sisi; Zhou, Bing; Song, Shuo; Tang, Xian; Yu, Jinfang; Lan, Jun; Yuan, Jing; Wang, Haiyan; Zhao, Juanjuan; Zhang, Shuye; Wang, Youchun; Shi, Xuanling; Liu, Lei; Zhao, Jincun; Wang, Xinquan*; Zhang, Zheng*; Zhang, Linqi*Nature, 2020, 584(7819): 115-+.
- Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicryGe, Jiwan; Wang, Ruoke; Ju, Bin; Zhang, Qi; Sun, Jing; Chen, Peng; Zhang, Senyan; Tian, Yuling; Shan, Sisi; Cheng, Lin; Zhou, Bing; Song, Shuo; Zhao, Juanjuan; Wang, Haiyan; Shi, Xuanling; Ding, Qiang; Liu, Lei; Zhao, Jincun; Zhang, Zheng*; Wang, Xinquan*; Zhang, Linqi*Nature Communications, 2021, 12(1): 250.被引 79
- Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domainWang, Yanqun*; Zhang, Zhaoyong; Yang, Minnan; Xiong, Xinyi; Yan, Qihong; Cao, Lei; Wei, Peilan; Zhang, Yuting; Zhang, Lu; Lv, Kexin; Chen, Jiantao; Liu, Xuesong; Zhao, Xiaochu; Xiao, Juxue; Zhang, Shengnan; Zhu, Airu; Gan, Mian; Zhang, Jingjun; Cai, Ruoxi; Zhuo, Jianfen; Zhang, Yanjun; Rao, Haiyue; Qu, Bin; Zhang, Yuanyuan; Chen, Lei; Dai, Jun; Cheng, Linling; Hu, Qingtao; Chen, Yaoqing; Lv, Huibin; So, Ray T. Y.; Peiris, Malik; Zhao, Jingxian; Liu, Xiaoqing*Cell Reports, 2024, 43(1): 113653.
